Format

Send to

Choose Destination
Nucleic Acids Res. 2014 Nov 10;42(20):e155. doi: 10.1093/nar/gku836. Epub 2014 Sep 15.

Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers.

Author information

1
Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, UK.
2
 Key laboratory of Regenerative Biology, GIBH, Chinese Academy of Sciences, Guangzhou 510530, China.
3
Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, UK  Shanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine Shanghai 200025. China pl2@sanger.ac.uk.
4
Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, UK  Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Universityof Cambridge, Tennis Court Rd, Cambridge CB2 1QR, UK pl2@sanger.ac.uk.

Abstract

The transcription activator-like effectors (TALEs) and the RNA-guided clustered regularly interspaced short palindromic repeat (CRISPR) associated protein (Cas9) utlilize distinct molecular mechanisms in targeting site recognition. The two proteins can be modified to carry additional functional domains to regulate expression of genomic loci in mammalian cells. In this study, we have compared the two systems in activation and suppression of the Oct4 and Nanog loci by targeting their enhancers. Although both are able to efficiently activate the luciferase reporters, the CRISPR/dCas9 system is much less potent in activating the endogenous loci and in the application of reprogramming somatic cells to iPS cells. Nevertheless, repression by CRISPR/dCas9 is comparable to or even better than TALE repressors. We demonstrated that dCas9 protein binding results in significant physical interference to binding of native transcription factors at enhancer, less efficient active histone markers induction or recruitment of activating complexes in gene activation. This study thus highlighted the merits and drawbacks of transcription regulation by each system. A combined approach of TALEs and CRISPR/dCas9 should provide an optimized solution to regulate genomic loci and to study genetic elements such as enhancers in biological processes including somatic cell reprogramming and guided differentiation.

PMID:
25223790
PMCID:
PMC4227760
DOI:
10.1093/nar/gku836
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center